Belgian Hospital 50th Transplant Center to Begin Certification Training To SynCardia Total Artificial Heart implanton Feb. 25 and 26, accompanied by the surgical team from Onze Lieve Vrouw Hospital Aalst, of surgeons Ivo Deblier, and Charles Dossche, and of anesthetists Koen de Decker is the first hospital in Belgium and the 50th Hospital in the world to be to complete the first phase of certification training for the SynCardia temporary Total Artificial Heart implant cardio. ‘The Total Artificial Heart has not equal in the world of mechanical circulatory support,’said Mary Pat Sloan, Vice President of Global Training and Customer Service SynCardia Systems, ‘It is the only device that replaces both failing heart ventricles and pumps up helping to 9.5 L / min through both sides of the heart, the patient recover faster.
John BO Mitchell and colleagues from the University of Cambridge are reporting development a method for the rapid identification of newly emerging designer steroids before they go into wider use in sports. Their study is in the November / December issue of the bimonthly scheduled ACS Journal of Chemical Information and Modeling. The scientists used chemotherapy computer science – research on the computer and information technology materials – to prohibited drugs into groups. Drugs in each group share similar chemical and biological properties.A few the key players health debates into news article Featured Today.
The U.S. Army for loss of hearing input Clinical TestingSound Pharmaceuticals launches clinical trials out of SPI-1005 for treatment and prevention of noise induced hearing.
Sound Pharmaceuticals is a biopharmaceutical company with focus on developing the first drugs for hearing loss and brain injury. For other information contact Jonathan Kil President and CEO 206-634-2559.